We are live on ! Find out more
HUMAW icon

Humacyte Inc Warrant
HUMAW

15 hedge funds and large institutions have $2.33M invested in Humacyte Inc Warrant in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

15% more funds holding

Funds holding: 13 → 15 (+2)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

34% less capital invested

Capital invested by funds: $3.51M → $2.33M (-$1.19M)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
2
Calls
$682K
Puts
–
Net Calls
+$682K
Net Calls Change
-$184K

Top Buyers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
+$350K
2
CH
CVI Holdings
Delaware
+$316K
3
ICM
Ionic Capital Management
New York
+$293K
4
DCP
Diameter Capital Partners
New York
+$69.7K
5
VF
Virtu Financial
New York
+$30.2K

Top Sellers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
-$350K
2
WAM
Warberg Asset Management
Illinois
-$103K
3
EAM
Exos Asset Management
New York
-$28.9K
4
WAM
Wolverine Asset Management
Illinois
-$8K
5
HF
HRT Financial
New York
-$2.66K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$665K +$316K +107,982 +59%
LP
2
LMR Partners
United Kingdom
$363K -$350K -119,683 -71%
LPL Financial
3
LPL Financial
California
$342K +$350K +119,792 +399%
ICM
4
Ionic Capital Management
New York
$229K +$293K +100,389 New
Jane Street
5
Jane Street
New York
$130K +$13.3K +4,562 +9%
HF
6
HRT Financial
New York
$121K -$2.66K -910 -2%
SCM
7
Sio Capital Management
New York
$114K – – –
AGM
8
Alpine Global Management
New York
$108K – – –
EAM
9
Exos Asset Management
New York
$62K -$28.9K -9,900 -27%
DCP
10
Diameter Capital Partners
New York
$54K +$69.7K +23,857 New
PSAMP
11
P. Schoenfeld Asset Management (PSAM)
New York
$44K – – –
ICMH
12
Integrity Capital Management (HK)
Hong Kong
$36K +$46.3K +15,830 New
Verition Fund Management
13
Verition Fund Management
Connecticut
$34K – – –
VF
14
Virtu Financial
New York
$24K +$30.2K +10,314 New
Morgan Stanley
15
Morgan Stanley
New York
$2K – – –
WAM
16
Warberg Asset Management
Illinois
– -$103K -35,662 Closed
WAM
17
Wolverine Asset Management
Illinois
– -$8K -2,959 Closed

HUMAW Hedge Fund Activity: Q4 2021 in Review

15 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2021, worth a combined $2.33M — down 34% from $3.51M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HUMAW positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was LPL Financial, adding an estimated $350K. The largest seller was LMR Partners, cutting an estimated $350K.

  • 15 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2021, up from 13 in Q3 2021.
  • Funds reported $2.33M of Humacyte Inc Warrant stock for Q4 2021, down 34% quarter-over-quarter.
  • 4 funds opened new Humacyte Inc Warrant positions in Q4 2021 and 2 closed out, a net change of +2 holders.
  • The largest Humacyte Inc Warrant buyer in Q4 2021 was LPL Financial, an estimated $350K added.
  • The largest Humacyte Inc Warrant seller in Q4 2021 was LMR Partners, an estimated $350K sold.

Based on aggregated 13F filings for Q4 2021.